World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
10676
World Ranking
2973
National Ranking
1398

Overview

Monica M. McNeal is affiliated with the University of Cincinnati Medical Center in the United States. Their research primarily focuses on medicine, with an emphasis on epidemiology, infectious diseases, hepatology, cardiology and cardiovascular medicine, as well as animal science and zoology. The scientist's work covers several main topics including viral gastroenteritis research and epidemiology, respiratory viral infections research, influenza virus research studies, hepatitis viruses studies and epidemiology, viral infections and immunology research, animal virus infections studies, and pneumonia and respiratory infections.

Recent publications by Monica M. McNeal include:

  • A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial (2020, Nature Medicine)
  • Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016 (2020, PEDIATRICS)
  • Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021 (2022, MMWR Morbidity and Mortality Weekly Report)
  • Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study (2021, PEDIATRICS)
  • Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial (2020, The Lancet Infectious Diseases)

Their frequent co-authors include Mary Allen Staat, Natasha Halasa, Geoffrey A. Weinberg, Rangaraj Selvarangan, and Eileen J. Klein. These colleagues have collaborated extensively, with several having co-authored more than two dozen works with McNeal.

Publication venues where Monica M. McNeal has frequently published include:

  • Open Forum Infectious Diseases
  • Journal of the Pediatric Infectious Diseases Society
  • Vaccine
  • The Journal of Infectious Diseases
  • Clinical Infectious Diseases

Monica M. McNeal's body of work contributes to understanding viral infections, particularly those affecting pediatric populations, and extends to vaccine development and surveillance efforts related to respiratory and gastrointestinal viruses. The focus on both epidemiological patterns and immunological responses encompasses broad efforts in infectious disease research within medical and microbiological fields.

Best Publications

  • A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.

    Raffael Nachbagauer;Jodi Feser;Abdollah Naficy;David I. Bernstein;David I. Bernstein

  • Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016.

    Brian Rha;Aaron T. Curns;Joana Y. Lively;Angela P. Campbell

  • Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.

    David I. Bernstein;Flor M. Munoz;S. Todd Callahan;Richard Rupp

  • Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial

    Mark C Steinhoff;Joanne Katz;Janet A Englund;Subarna K Khatry

  • Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-γ in experimental biliary atresia

    Pranavkumar Shivakumar;Kathleen M. Campbell;Gregg E. Sabla;Alexander Miethke

  • The Burden of Influenza in Young Children, 2004–2009

    Katherine A. Poehling;Kathryn M. Edwards;Marie R. Griffin;Peter G. Szilagyi

  • Development of an adult mouse model for studies on protection against rotavirus.

    R L Ward;M M McNeal;J F Sheridan

  • Immune response to influenza vaccine in children with inflammatory bowel disease

    Ying Lu;Denise L Jacobson;Lori A Ashworth;Richard J Grand

  • IgA and Neutralizing Antibodies to Influenza A Virus in Human Milk: A Randomized Trial of Antenatal Influenza Immunization

    Elizabeth P. Schlaudecker;Mark C. Steinhoff;Saad B. Omer;Monica M. McNeal

  • Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011

    Daniel C. Payne;Julie A. Boom;Julie A. Boom;Mary Allen Staat;Kathryn M. Edwards

  • Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus.

    R. L. Ward;D. I. Bernstein;Rakesh Shukla;E. C. Young

  • Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger

    Sheila Isanaka;Ousmane Guindo;Celine Langendorf;Amadou Matar Seck

  • Predicting Susceptibility to Norovirus GII.4 by Use of a Challenge Model Involving Humans

    Robert Frenck;David I Bernstein;David I Bernstein;Ming Xia;Pengwei Huang

  • Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production

    Ming Tan;Pengwei Huang;Ming Xia;Ping-An Fang

  • Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice.

    Monica McNeal;K S Barone;M N Rae;Richard Ward

  • Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses — New Vaccine Surveillance Network, United States, 2016–2021

    Unknown

  • CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

    Monica M. McNeal;John L. VanCott;Anthony H. C. Choi;Matili Basu

  • Antibody-Independent Protection against Rotavirus Infection of Mice Stimulated by Intranasal Immunization with Chimeric VP4 or VP6 Protein

    Anthony H.-C. Choi;Mitali Basu;Monica M. McNeal;John D. Clements

  • Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

    David I Bernstein;David I Bernstein;Jeffrey Guptill;Abdollah Naficy;Raffael Nachbagauer

  • Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

    Michelle J Groome;Anthonet Koen;Alan Fix;Nicola Page;Nicola Page

  • Effector Role of Neonatal Hepatic CD8+ Lymphocytes in Epithelial Injury and Autoimmunity in Experimental Biliary Atresia

    Pranavkumar Shivakumar;Gregg Sabla;Sujit Mohanty;Monica McNeal

  • Development of a Rotavirus-Shedding Model in Rhesus Macaques, Using a Homologous Wild-Type Rotavirus of a New P Genotype

    Monica M. McNeal;Karol Sestak;Anthony H.-C. Choi;Mitali Basu

Frequent Co-Authors

Richard L. Ward
Richard L. Ward Cincinnati Children's Hospital Medical Center
Peter G. Szilagyi
Peter G. Szilagyi University of California, Los Angeles
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
Geoffrey A. Weinberg
Geoffrey A. Weinberg University of Rochester
Natasha Halasa
Natasha Halasa Vanderbilt University Medical Center
David I. Bernstein
David I. Bernstein University of Cincinnati
Umesh D. Parashar
Umesh D. Parashar Centers for Disease Control and Prevention
John V. Williams
John V. Williams University of Pittsburgh
Xi Jiang
Xi Jiang Cincinnati Children's Hospital Medical Center
Michael D. Bowen
Michael D. Bowen Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related degrees in nursing and healthcare offers diverse career opportunities. Many professionals start with accelerated programs, such as accelerated FNP programs, which fast-track the path to becoming a Family Nurse Practitioner. These programs are ideal for those seeking to combine patient care with immunology knowledge.

For nurses looking to specialize further, acnp programs offer advanced training in acute care, aligning closely with immunology’s focus on immune-related diseases and treatments. These programs often lead to higher-level clinical responsibilities and research opportunities.

Individuals without a nursing background can also enter the field through online accelerated nursing programs for non nurses. These flexible options provide foundational knowledge quickly, opening doors to immunology-related nursing roles.

For those beginning their nursing journey, choosing from the easiest ABSN to get into can simplify entry into the field. These programs typically focus on accessibility and expedited coursework, allowing students to move efficiently toward immunology-focused career paths.

Best Scientists Citing Monica M. McNeal

Trending Scientists

Recently Published Articles